RT Journal Article
SR Electronic
T1 CT-derived measurements of pulmonary blood volume in small vessels and need for oxygen in COVID-19 patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.03.20121483
DO 10.1101/2020.06.03.20121483
A1 De Backer, Wilfried
A1 Lins, Muriel
A1 Dierckx, Wendel
A1 Vandevenne, Jan
A1 De Backer, Jan
A1 Lavon, Ben R.
A1 Lanclus, Maarten
A1 Rijckaert, Karen
A1 Kendall, Irvin
A1 Thillai, Muhunthan
YR 2020
UL http://medrxiv.org/content/early/2020/07/02/2020.06.03.20121483.abstract
AB In contrast to early reports of conventional acute respiratory distress syndrome (ARDS) as the underlying pathophysiology of hypoxemic respiratory failure observed in patients with severe COVID-19, more recent findings implicate direct involvement of the pulmonary vasculature in giving rise to these symptoms. In earlier research, we demonstrated that patients with COVID-19 showed markedly reduced pulmonary blood volumes in pulmonary vessels <5 mm2 in cross-sectional area visible on imaging (termed “BV5”), with attendant dilation of larger, more proximal vessels. Here, we present preliminary results in which reduced BV5 is shown to correlate significantly with increased need for supplemental oxygen and abnormal arterial blood gas measurements in hospitalized COVID-19 patients. We suggest a potential mechanistic link between observed clinical, pathological, and imaging findings, and outline how these may be helpful in clinical assessment as well as the development of novel therapies.Competing Interest StatementWD, JDB, BL, ML, IK, and KR are employees of FLUIDDA, a company that develops and markets part of the technology described in this paper. The other authors have no financial relationships with any organization or company that might have an interest in the submitted work and received no direct funding from FLUIDDA. No funding was received for this research.Funding StatementNo external funding was received for the research reported in this manuscriptAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The authors declare that this report does not contain any personal information that could lead to the identification of the patient(s). The authors declare that they obtained a written informed consent from the patients and/or volunteers included in the article. The authors also confirm that the personal details of the patients and/or volunteers have been removed. All patient data were provided under the oversight of local ethical committees.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll patient data is available upon request from the corresponding author.